Dr. Cristofanilli on Endocrine Therapy for Breast Cancer

Massimo Cristofanilli, MD
Published: Sunday, Sep 17, 2017



Massimo Cristofanilli, MD, professor of medicine, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, discusses endocrine therapy for patients with breast cancer.

According to Cristofanilli, endocrine therapy is the most important therapy that is used in adjuvant prevention and management of metastatic breast cancer. The vast majority of patients with breast cancer have an estrogen receptor (ER)-positive disease, which responds well to endocrine therapy.

Understanding the molecular pathway has helped the development of new drugs for patients, states Cristofanilli.
 


Massimo Cristofanilli, MD, professor of medicine, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, discusses endocrine therapy for patients with breast cancer.

According to Cristofanilli, endocrine therapy is the most important therapy that is used in adjuvant prevention and management of metastatic breast cancer. The vast majority of patients with breast cancer have an estrogen receptor (ER)-positive disease, which responds well to endocrine therapy.

Understanding the molecular pathway has helped the development of new drugs for patients, states Cristofanilli.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x